Clover Health Investments (Clover Health Investments) EBIT : $-163 Mil (TTM As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Clover Health Investments EBIT?

Clover Health Investments's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2024 was $-22 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2024 was $-163 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Clover Health Investments's annualized ROC % for the quarter that ended in Mar. 2024 was -53.17%. Clover Health Investments's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -1,064.48%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Clover Health Investments's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -107.07%.

Clover Health Investments EBIT Historical Data

The historical data trend for Clover Health Investments's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clover Health Investments EBIT Chart

Clover Health Investments Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT

-324.67

-79.28

-570.85

-338.20

-213.35

Clover Health Investments Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EBIT	Get a 7-Day Free Trial													-77.89	-28.81	-41.47	-70.47	-22.35

Competitive Comparison of Clover Health Investments's EBIT

For the Healthcare Plans subindustry, Clover Health Investments's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Clover Health Investments's EV-to-EBIT Distribution in the Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, Clover Health Investments's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Clover Health Investments's EV-to-EBIT falls into.

Clover Health Investments EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-163 Mil.

Clover Health Investments (NAS:CLOV) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Clover Health Investments's annualized ROC % for the quarter that ended in Mar. 2024 is calculated as:

	ROC % (Q: Mar. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Dec. 2023 )	+	Invested Capital (Q: Mar. 2024 ))	/ count )
=	-89.4 * ( 1 - 0% )	/	( (164.05	+	172.204)	/ 2 )
=	-89.4	/	168.127
=	-53.17 %

where

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	570.671	-	239.766	-	( 298.316	-	max(0, 261.115	-	427.97	+	298.316	))
=	164.05

	Invested Capital		(Q: Mar. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	671.77	-	303.218	-	( 343.094	-	max(0, 356.389	-	552.737	+	343.094	))
=	172.204

Note: The Operating Income data used here is four times the quarterly (Mar. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Clover Health Investments's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Mar. 2024 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Dec. 2023		Q: Mar. 2024
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-89.4	/	( ( (8.464 + max(-243.628, 0))	+	(8.333 + max(-322.13, 0)) )	/	2 )
=	-89.4	/	( ( 8.464	+	8.333 )	/	2 )
=	-89.4	/	8.3985
=	-1,064.48 %

where Working Capital is:

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0	+	0	+	15.822)	-	(239.766	+	3.099	+	16.585)
=	-243.628

	Working Capital		(Q: Mar. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0	+	0	+	32.636)	-	(303.218	+	0	+	51.548)
=	-322.13

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Clover Health Investments's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Mar. 2024 )
	=	-163.098	/	152.322
	=	-107.07 %

Clover Health Investments EBIT Related Terms

Thank you for viewing the detailed overview of Clover Health Investments's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Clover Health Investments (Clover Health Investments) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Clover Health Investments Corp (NAS:CLOV) » Definitions » EBIT

Comparable Companies

BHG PFHO MRAI OSCR ALHC UNH ELV CI CVS HUM CNC MOH SZSE:000503 BSP:ODPV3 BSP:QUAL3 ROCO:6665 MIL:HI TSXV:NXG

Traded in Other Exchanges

7QD:Germany

Address

3401 Mallory Lane, Suite 210, Franklin, TN, USA, 37067

Website

https://www.cloverhealth.com

Clover Health Investments Corp is a healthcare technology company. It uses its proprietary technology platform to collect, structure, & analyze health & behavioral data to improve medical outcomes & lower costs for patients. The Group has two operating segments. The insurance segment provides PPO(Preferred provider Organization) & HMO(Health Maintenance Organization) plans to Medicare Advantage members in several states & seeks to improve care & lower costs which generally provide access to a wide network of primary care providers, specialists, & hospitals. Non-insurance segment includes the Company's operations relating to CMS' DC (Direct Contracting) Model, which provides options aimed at reducing expenditures & preserving or enhancing the quality of care for beneficiaries.

Executives

Karen Soares	officer: General Counsel & Secretary	3401 MALLORY LANE, SUITE 210, FRANKLIN TN 37067
Clover Health Investments, Corp. /de	officer: Chief Technology Officer	3401 MALLORY LANE, SUITE 210, FRANKLIN TN 37067
Anna U Loengard	director	C/O CLOVER HEALTH INVESTMENTS, CORP., 3401 MALLORY LANE, SUITE 210, FRANKLIN TN 37067
Andrew Toy	director, officer: Chief Executive Officer	C/O CLOVER HEALTH INVESTMENTS, CORP., 725 COOL SPRINGS BLVD., SUITE 320, FRANKLIN TN 37067
Scott J. Leffler	officer: Chief Financial Officer	C/O CLOVER HEALTH INVESTMENTS, CORP., 3401 MALLORY LANE, SUITE 210, FRANKLIN TN 37067
Brady Patrick Priest	officer: CEO of Home Care	C/O CLOVER HEALTH INVESTMENTS, CORP., FRANKLIN TN 37067
Demetrios L. Kouzoukas	director	C/O CLOVER HEALTH INVESTMENTS, CORP., 725 COOL SPRINGS BLVD., SUITE 320, FRANKLIN FL 37067
Aric R Sharp	officer: CEO of Value-Based Care	C/O CLOVER HEALTH INVESTMENTS, CORP., 3401 MALLORY LANE, SUITE 210, FRANKLIN TN 37067
Wai Conrad	officer: Chief Technology Officer	3401 MALLORY LANE, SUITE 210, FRANKLIN TN 37067
Joseph Richards Martin	officer: General Counsel	C/O LOUISIANA-PACIFIC CORPORATION, 414 UNION STREET, SUITE 2000, NASHVILLE TN 37219
Vivek Garipalli	director, 10 percent owner, officer: Executive Chairperson	C/O CLOVER HEALTH INVESTMENTS, CORP., 725 COOL SPRINGS BLVD., SUITE 320, FRANKLIN TN 37067
Carladenise Armbrister Edwards	director	C/O CLOVER HEALTH INVESTMENTS, CORP., 3401 MALLORY LANE, SUITE 210, FRANKLIN TN 37067
Chelsea Clinton	director	C/O IAC 555 W 18TH STREET, NEW YORK NY 10011
Jamie L. Reynoso	officer: CEO of Medicare Advantage	C/O CLOVER HEALTH INVESTMENTS, CORP., 725 COOL SPRINGS BLVD., SUITE 320, FRANKLIN TN 37067
Chamath Palihapitiya	10 percent owner, other: See Remarks	THE SOCIAL-CAPITAL PARTNERSHIP, L.L.C., 506 SANTA CRUZ AVENUE, SUITE 300, MENLO PARK CA 94025